Modeling protein-protein interactions requires accurate scoring functions that can rank potential poses (conformations) of a protein-protein complex to differentiate near-native poses from incorrect ones. Here, we propose a general framework for improving protein-protein pose ranking and other biomolecular interaction models using the LambdaLoss loss function from the Learning-to-Rank field. We test this framework by fine-tuning the energy prediction head of DFMDock with the LambdaLoss on an augmented dataset of 2.9M decoy poses derived from the DIPS dataset. On targets from the CAPRI score set benchmark, our fine-tuned ranking model LambdaDockScore is better at identifying correct poses in its top-1 and top-5 predictions compared to EuDockScore, a state-of-the-art method. LambdaDockScore also improves upon baseline DFMDock ranking performance for scoring antibody-antigen complexes and protein-protein complexes with very large or small binding interfaces.
Figures & tables
Figure 1: Benchmarking results on 69 protein-protein complexes from the CAPRI Score Set (filtered for <30% seq. identity to training data). Each complex averaged ∼ 1.1k decoys. The top-1 and top-5 ranked decoys from each model were analyzed. Exact success rates for all models are provided in Supplementary Table S3 .
Figure 2: Benchmarking results on 253 protein-protein complexes from Docking Benchmark 5.5. 120 decoys were generated per protein-protein complex using baseline DFMDock. The top-1 and top-5 ranked decoys from each model were analyzed. DFMDock with LambdaDockScore as its ranking model outperforms baseline DFMDock on both top-1 and top-5 ranking accuracy for acceptable and medium quality poses. Bar heights show the mean performance from 10,000 bootstrap samples, and error bars show the 95% confidence interval. Exact success rates and 95% confidence intervals are provided in Supplementary Table S4 .
Figure 3: Benchmarking results on antibody-antigen complexes from Docking Benchmark 5.5. Results are for 120 decoys generated and ranked per protein-protein complex. DFMDock with LambdaDockScore as its ranking model (red) outperforms baseline DFMDock (blue). Exact success rates and 95% confidence intervals are provided in Supplementary Table S5 .
Appendix figures & tables10 assets
Supplementary material from the paper’s appendix.
Appendix
Decoy set
Translation std. dev. (Å)
Rotation std dev. (°)
# poses
Perturbed GT — small
0.1
1.0
20
Perturbed GT — medium
1.0
7.0
100
Perturbed GT — large
2.5
20.0
100
DFMDock samples
N/A
N/A
50
Total (per GT complex)
270
Appendix
Table S1: Decoy pose sampling details. GT stands for ground truth. Standard deviations are for Normal distributions centered at 0, which were used to sample random translations and rotations for the perturbed GT poses.
Figure S1: Distribution of poses for eight randomly sampled protein-protein complexes from the DIPS-hetero fine-tuning dataset. The majority of complexes in the fine-tuning dataset have a distribution of poses across the full DockQ [0,1] interval, though some complexes lack sufficient numbers of high DockQ poses.
Figure S2: Top- k success rate on the CAPRI score set (69 complexes) for LambdaDockScore (red), baseline DFMDock (blue), and EuDockScore (purple), shown for high (left), medium (center), and acceptable (right) quality thresholds. Each curve is the percentage of complexes with at least one pose above the quality threshold among the k lowest-energy poses.
Figure S3: Top- k success rate on DB5.5 (253 complexes) for LambdaDockScore (red) and baseline DFMDock (blue), shown for high (left), medium (center), and acceptable (right) quality thresholds. Poses were sampled with baseline DFMDock and ranked by each model. Each curve is the percentage of complexes with at least one pose above the quality threshold among the k lowest-energy poses.
Figure S4: Benchmarking results on Docking Benchmark 5.5, segmented by the change in accessible surface area ( Δ ASA). This is a measure of how the model performs based on the size of the binding interface. Protein-protein complexes were ordered by Δ ASA and split into five evenly sized bins based on their Δ ASA percentile. Panels (a)-(e) show the performance of baseline DFMDock’s energy prediction head (blue) compared to LambdaDockScore (red) for each bin, in order of increasing interface size. Exact success rates and 95% confidence intervals are provided in Supplementary Table S6 .
Δ ASA bin
Targets
Targets with zero acceptable poses
Percent with zero acceptable poses
0–20th
51
32
62.7%
20–40th
50
30
60%
40–60th
51
36
70.6%
60–80th
50
34
68%
80–100th
51
30
58.8%
Appendix
Table S2: The number of target complexes in each Δ ASA percentile bin, the number containing no acceptable pose among the sampled decoys, and the percent of target complexes with no acceptable pose.
Evaluation Metric
Model
Acceptable (%)
Medium (%)
High (%)
Top-1
Baseline DFMDock
30.4
17.4
7.2
Top-1
LambdaDockScore
31.9
26.1
1.4
Top-1
EuDockScore
20.3
13.0
0.0
Top-5
Baseline DFMDock
44.9
31.9
7.2
Top-5
LambdaDockScore
49.3
34.8
7.2
Top-5
EuDockScore
40.6
26.1
4.3
Appendix
Table S3: Success rates for the CAPRI Score Set (n=69), corresponding to Figure 1 .
Evaluation Metric
Model
Acceptable (%) [95% CI]
Medium (%) [95% CI]
High (%) [95% CI]
Top-1
Baseline DFMDock
3.4 [2.4, 4.3]
0.8 [0.4, 1.6]
0.0 [0.0, 0.0]
Top-1
LambdaDockScore
5.0 [3.6, 6.3]
1.3 [0.8, 2.0]
0.3 [0.0, 0.4]
Top-5
Baseline DFMDock
7.2 [5.5, 8.7]
2.0 [1.2, 2.8]
0.2 [0.0, 0.4]
Top-5
LambdaDockScore
9.4 [7.9, 11.1]
2.3 [1.6, 3.2]
0.3 [0.0, 0.4]
Oracle
Baseline DFMDock
31.1 [28.9, 33.2]
6.1 [4.7, 7.1]
0.3 [0.0, 0.4]
Oracle
LambdaDockScore
31.1 [28.9, 33.2]
6.1 [4.7, 7.1]
0.3 [0.0, 0.4]
Appendix
Table S4: Success rates and 95% confidence intervals for DB5.5 (n=253), corresponding to Figure 2 . Success rate values represent the mean performance from 10,000 pose-bootstrap samples.
Evaluation Metric
Model
Acceptable (%) [95% CI]
Medium (%) [95% CI]
High (%) [95% CI]
Top-1
Baseline DFMDock
1.2 [0.0, 1.8]
0.0 [0.0, 0.0]
0.0 [0.0, 0.0]
Top-1
LambdaDockScore
1.9 [0.0, 3.6]
0.0 [0.0, 0.0]
0.0 [0.0, 0.0]
Top-5
Baseline DFMDock
2.5 [0.0, 5.5]
0.0 [0.0, 0.0]
0.0 [0.0, 0.0]
Top-5
LambdaDockScore
5.1 [1.8, 7.3]
0.0 [0.0, 0.0]
0.0 [0.0, 0.0]
Oracle
Baseline DFMDock
17.6 [14.5, 20.0]
0.0 [0.0, 0.0]
0.0 [0.0, 0.0]
Oracle
LambdaDockScore
17.6 [14.5, 20.0]
0.0 [0.0, 0.0]
0.0 [0.0, 0.0]
Appendix
Table S5: Success rates and 95% confidence intervals for DB5.5 Antibody-Antigen Complexes (n=55), corresponding to Figure 3 . Success rate values represent the mean performance from 10,000 pose-bootstrap samples.
Δ ASA Bin
Metric
Model
Acceptable (%) [95% CI]
Medium (%) [95% CI]
High (%) [95% CI]
0–20th pct (799-1316 Å 2 n=51)
Top-1
Baseline DFMDock
0.2 [0.0, 2.0]
0.2 [0.0, 2.0]
0.0 [0.0, 0.0]
Top-1
LambdaDockScore
2.1 [0.0, 5.9]
0.2 [0.0, 2.0]
0.0 [0.0, 0.0]
Top-5
Baseline DFMDock
1.9 [0.0, 3.9]
1.2 [0.0, 2.0]
0.0 [0.0, 0.0]
Top-5
LambdaDockScore
7.6 [3.9, 11.8]
1.7 [0.0, 3.9]
0.0 [0.0, 0.0]
Oracle
Baseline DFMDock
31.5 [25.5, 37.3]
5.0 [2.0, 7.8]
0.0 [0.0, 0.0]
Oracle
LambdaDockScore
31.5 [25.5, 37.3]
5.0 [2.0, 7.8]
0.0 [0.0, 0.0]
Appendix
Table S6: Success rates and 95% confidence intervals for DB5.5 split into 5 Δ ASA bins, corresponding to Supplementary Figure S4 . Success rate values represent the mean performance from 10,000 pose-bootstrap samples across 5 interface area bins.
Protein-protein interaction prediction uses sequence, structure, and biological networks to identify interacting proteins and their binding sites or poses.
Department of Computer Science and Engineering The Chinese University of Hong Kong Shatin, N.T., Hong Kong SAR · Department of Electrical and Computer Engineering Rutgers University Piscataway, NJ · Computational Life Sciences Cleveland Clinic Cleveland, OH +1
Department of Bioengineering and Therapeutic Sciences, Schools of Pharmacy and Medicine, University of California, San Francisco, San Francisco, CA, USA · UCSF–Stanford Center of Excellence in Regulatory Science and Innovation (CERSI), San Francisco, CA, USA
May 21, 2026·Zhaohan Meng, Zhen Bai, Ke Yuan +4Drug Discovery
School of Computing Science, University of Glasgow · School of Life Science and Technology, Institute of Science Tokyo · School of Cancer Sciences, University of Glasgow +4